131 related articles for article (PubMed ID: 2479240)
1. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
Ikemoto I; Machida T; Oishi Y; Onishi T; Shirai T; Imanaka K
Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
[TBL] [Abstract][Full Text] [Related]
2. [Clinical application of immunoenzyme assay for prostatic acid phosphatase].
Yoshida K; Sato S; Nishimura T; Akimoto M
Hinyokika Kiyo; 1989 Oct; 35(10):1819-22. PubMed ID: 2692448
[TBL] [Abstract][Full Text] [Related]
3. [Prostatic acid phosphatase by enzymeimmunoassay].
Masukagami T; Ando K; Shimazaki J
Hinyokika Kiyo; 1984 Nov; 30(11):1691-5. PubMed ID: 6084950
[TBL] [Abstract][Full Text] [Related]
4. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
[TBL] [Abstract][Full Text] [Related]
5. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of a monoclonal antibody-based enzyme immunoassay (IQ(Bio) PAP-AELIA kit) for prostatic acid phosphatase].
Koshida K; Naito K; Hisazumi H
Hinyokika Kiyo; 1987 Oct; 33(10):1703-7. PubMed ID: 3328502
[TBL] [Abstract][Full Text] [Related]
7. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
Gaca A; Panitz N
Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
Miki M
Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
[TBL] [Abstract][Full Text] [Related]
9. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
Bauer HW; Schmiedt E
Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
Tsukamoto T; Kumamoto Y; Yamazaki K; Umehara T; Miyao N; Ohmura K; Iwazawa M
Hinyokika Kiyo; 1988 Jun; 34(6):987-95. PubMed ID: 2464917
[TBL] [Abstract][Full Text] [Related]
11. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
Vihko P; Lukkarinen O; Kontturi M; Vihko R
Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
[TBL] [Abstract][Full Text] [Related]
12. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
Hamami G
Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
[TBL] [Abstract][Full Text] [Related]
13. [Prostatic acid phosphatase measured by immunoenzyme assay].
Fuse H; Zama S; Shimazaki J
Hinyokika Kiyo; 1985 Nov; 31(11):1957-64. PubMed ID: 2418660
[TBL] [Abstract][Full Text] [Related]
14. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
Foti AG; Cooper JF; Herschman H; Malvaez RR
N Engl J Med; 1977 Dec; 297(25):1357-61. PubMed ID: 73133
[TBL] [Abstract][Full Text] [Related]
15. [Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase].
Rassweiler J; Lutz K; Müller HA; Eisenberger F
Urologe A; 1988 Jan; 27(1):32-5. PubMed ID: 2452506
[TBL] [Abstract][Full Text] [Related]
16. [Experience with prostate-specific antigen in patients with prostatic cancer].
Romics I; Bach D
Orv Hetil; 1989 Dec; 130(52):2797-800. PubMed ID: 2481833
[TBL] [Abstract][Full Text] [Related]
17. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
Moul JW; Connelly RR; Perahia B; McLeod DG
J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
[TBL] [Abstract][Full Text] [Related]
18. Double-antibody immunoenzyme assay for human prostatic acid phosphatase.
Choe BK; Pontes EJ; Dong MK; Rose NR
Clin Chem; 1980 Dec; 26(13):1854-9. PubMed ID: 6159996
[TBL] [Abstract][Full Text] [Related]
19. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
[TBL] [Abstract][Full Text] [Related]
20. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
Morote Robles J; de Torres Mateos JA
Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
